Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Background Despite unprecedented benefit from immune checkpoint inhibitors (ICIs) in patients with mismatch repair deficient (dMMR)/microsatellite instability high (MSI-H) advanced gastrointestinal cancers, a relevant proportion of patients shows primary resistance or short-term disease control. Sin...

Full description

Bibliographic Details
Main Authors: Ambrosini, M. (Author), Andre, T. (Author), Bergamo, F. (Author), Chao, J. (Author), Chida, K. (Author), Cohen, R. (Author), Colle, R. (Author), Conca, V. (Author), Corti, F. (Author), Cremolini, C. (Author), Curigliano, G. (Author), Elez, M.E (Author), Emmett, M. (Author), Fakih, M. (Author), Fenocchio, E. (Author), Fucà, G. (Author), Garciá, M.D (Author), Jayachandran, P. (Author), Kawazoe, A. (Author), Klempner, S.J (Author), Lonardi, S. (Author), Mazzoli, G. (Author), Overman, M. (Author), Pietrantonio, F. (Author), Provenzano, L. (Author), Randon, G. (Author), Salati, M. (Author), Salvatore, L. (Author), Shah, A.T (Author), Shitara, K. (Author), Svrcek, M. (Author)
Format: Article
Language:English
Published: BMJ Publishing Group 2022
Subjects:
Online Access:View Fulltext in Publisher